Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
Go back to Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer| (NASDAQ: IMUX) | Delayed: 14.97 +0.22 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.75 | 52 Week High | $ | |||
| Open | $14.48 | 52 Week Low | $ | |||
| Day High | $15.41 | P/E | N/A | |||
| Day Low | $14.12 | EPS | $ | |||
| Volume | 67,971 | |||||

